Literature DB >> 14638710

Optokinetic nystagmus in strabismus: are asymmetries related to binocularity?

Christophe Valmaggia1, Frank Proudlock, Irene Gottlob.   

Abstract

PURPOSE: Strabismus may be associated with an asymmetry of monocular horizontal optokinetic nystagmus (OKN). It is unclear whether OKN asymmetries are associated with deficiency in binocular and/or stereovision. In the current study, patients with different degrees of binocularity were investigated.
METHODS: OKN was examined in the dominant and nondominant eyes of four groups of patients: (1) no measurable binocularity (NB), (2) poor binocularity (PB)-that is, showing binocularity on the Bagolini Test and/or rudimentary stereovision, (3) good binocularity (GB) with good stereoacuity after squint surgery, and (4) a control group. Monocular OKN was elicited with black-and-white stripes moving temporally to nasally (TN) or nasally to temporally (NT) at velocities of 15, 30, 45, and 60 deg/s. Eye movements were recorded with infrared oculography.
RESULTS: Only subjects in the NB group showed a significant OKN asymmetry, with preference for TN stimulation in dominant and nondominant eyes. Subjects with PB did not have significant OKN asymmetries but reduced OKN gains in both stimulus directions. Subjects with GB had normal mean OKN gains without asymmetry. Larger OKN asymmetries were correlated with younger age at detection of strabismus if NB and GB were grouped together, but not if each group was analyzed separately.
CONCLUSIONS: For the first time, a large groups of patients classified by level of binocular vision has been investigated. The results show that OKN gain and asymmetry are associated with the development of binocular vision. OKN investigation may be helpful to identify patients with binocularity or binocular potential in strabismus.

Entities:  

Mesh:

Year:  2003        PMID: 14638710     DOI: 10.1167/iovs.03-0322

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Effect of binocular rivalry suppression on initial ocular following responses.

Authors:  Mingxia Zhu; Richard W Hertle; Chang H Kim; Xuefeng Shi; Dongsheng Yang
Journal:  J Vis       Date:  2008-04-23       Impact factor: 2.240

2.  An assessment of optokinetic nystagmus (OKN) in persons with Down syndrome.

Authors:  Alberto C S Costa
Journal:  Exp Brain Res       Date:  2011-08-14       Impact factor: 1.972

3.  Vergence nystagmus induced by motion in the ground plane: normal response characteristics.

Authors:  Dongsheng Yang; Mingxia Zhu; Chang H Kim; Richard W Hertle
Journal:  Vision Res       Date:  2007-03-23       Impact factor: 1.886

4.  Motion Information via the Nonfixating Eye Can Drive Optokinetic Nystagmus in Strabismus.

Authors:  Sevda Agaoglu; Mehmet N Agaoglu; Vallabh E Das
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

Review 5.  Timing of surgery for infantile esotropia: sensory and motor outcomes.

Authors:  Agnes M F Wong
Journal:  Can J Ophthalmol       Date:  2008-12       Impact factor: 1.882

6.  Age related change of optokinetic nystagmus in healthy subjects: a study from infancy to senescence.

Authors:  C Valmaggia; A Rütsche; A Baumann; C Pieh; Y Bellaiche Shavit; F Proudlock; I Gottlob
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

7.  A Dichoptic Optokinetic Nystagmus Paradigm for Interocular Suppression Quantification in Intermittent Exotropia.

Authors:  Xiaoxiao Cai; Zidong Chen; Yanping Liu; Daming Deng; Minbin Yu
Journal:  Front Neurosci       Date:  2021-12-03       Impact factor: 4.677

8.  Normative data for ages 18-45 for ocular motor and vestibular testing using eye tracking.

Authors:  Aura Kullmann; Robin C Ashmore; Alexandr Braverman; Christian Mazur; Hillary Snapp; Erin Williams; Mikhaylo Szczupak; Sara Murphy; Kathryn Marshall; James Crawford; Carey D Balaban; Michael Hoffer; Alexander Kiderman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-08-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.